Palisade Bio, Inc. (PALI)
2.01
-0.04
(-1.95%)
USD |
NASDAQ |
Sep 10, 16:00
2.05
+0.04
(+1.99%)
After-Hours: 20:00
Palisade Bio Price : 2.01 for Sept. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 2.05 | 2.11 | 2.01 | 2.01 | 2.646M |
| Sep 09, 2026 | 2.17 | 2.21 | 2.05 | 2.05 | 2.775M |
| Sep 08, 2026 | 2.09 | 2.235 | 2.08 | 2.20 | 3.530M |
| Sep 04, 2026 | 2.03 | 2.12 | 2.00 | 2.09 | 1.755M |
| Sep 03, 2026 | 2.01 | 2.05 | 1.97 | 2.045 | 1.087M |
| Sep 02, 2026 | 1.96 | 2.005 | 1.95 | 1.99 | 731450.0 |
| Sep 01, 2026 | 1.96 | 1.98 | 1.915 | 1.96 | 879448.0 |
| Aug 31, 2026 | 2.02 | 2.02 | 1.93 | 1.95 | 1.646M |
| Aug 28, 2026 | 2.10 | 2.112 | 1.99 | 2.00 | 2.127M |
| Aug 27, 2026 | 2.12 | 2.16 | 2.095 | 2.11 | 899220.0 |
| Aug 26, 2026 | 2.06 | 2.135 | 2.032 | 2.13 | 1.191M |
| Aug 25, 2026 | 2.02 | 2.10 | 1.98 | 2.07 | 2.068M |
| Aug 24, 2026 | 2.10 | 2.10 | 2.00 | 2.01 | 1.619M |
| Aug 21, 2026 | 2.09 | 2.135 | 2.08 | 2.10 | 1.070M |
| Aug 20, 2026 | 2.14 | 2.15 | 2.03 | 2.06 | 1.325M |
| Aug 19, 2026 | 2.10 | 2.19 | 2.085 | 2.16 | 2.290M |
| Aug 18, 2026 | 2.15 | 2.15 | 2.01 | 2.04 | 2.286M |
| Aug 17, 2026 | 2.13 | 2.22 | 2.10 | 2.15 | 1.404M |
| Aug 14, 2026 | 2.12 | 2.15 | 2.06 | 2.14 | 1.605M |
| Aug 13, 2026 | 1.99 | 2.15 | 1.98 | 2.15 | 2.467M |
| Aug 12, 2026 | 2.14 | 2.18 | 1.95 | 1.96 | 2.377M |
| Aug 11, 2026 | 2.05 | 2.15 | 2.05 | 2.14 | 1.246M |
| Aug 10, 2026 | 2.05 | 2.10 | 2.03 | 2.10 | 1.309M |
| Aug 07, 2026 | 2.08 | 2.118 | 2.05 | 2.11 | 886468.0 |
| Aug 06, 2026 | 2.09 | 2.15 | 2.07 | 2.09 | 779181.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.74 |
| Alnylam Pharmaceuticals, Inc. | 247.51 |
| Anika Therapeutics, Inc. | 20.99 |
| Savara, Inc. | 5.32 |
| Vericel Corp. | 37.87 |
Price Related Metrics
| PS Ratio | 590.90 |
| Price to Book Value | 2.866 |
| Earnings Yield | -26.63% |
| Market Cap | 348.93M |